Meet Dr Santosh Valvi, a paediatric oncologist at Perth Children’s Hospital. Santosh is just one of the incredible medical professionals that played a crucial role in helping Luca recover from a very rare and aggressive form of brain cancer.
Luca’s mum, Brooke was told her then three-year-old daughter only had a tiny chance of survival. Over the course of more than a year, Luca endured surgery, chemotherapy, stem cell transplants and daily radiation. It was a gruelling seven-month journey.
Despite overcoming the odds Luca still faces an uncertain future – there is simply no way to know if she will ever make a full recovery.
However, with your help, we can develop better treatments for kids like Luca, as well as conduct more research to help reduce the often-toxic side-effects of current treatments. Â
Thanks to generous support from our donors, Perth Children’s Hospital Foundation has recently funded three pieces of cutting-edge cancer research equipment. The technology is helping researchers working on clinical trials analyse tumour samples and medications faster, and in more detail.  Â
The equipment also reduces manual handling during experiments, saving time, and ensuring more accurate and reliable results. Â
For patients who relapse – where brain cancer returns despite treatment – having more accurate information available helps doctors create personalised treatment plans and targeted therapies. This is giving WA kids the best possible chance at survival.  Â
MultiFlo FX – streamlines research workflows and improves the accuracy and quality of research data, including evaluating new types of tumour treatments and the impacts on cancer cell survival.  Â
Mantra Pathology Workstation – a process that used to take seven weeks can now be done in just one week. Comprising a multifunctional microscope, digital camera, computer and image analysis software, the workstation provides faster, more accurate analysis of new drugs and therapies.   Â
Tecan digital dispenser – enables quicker, more accurate drug screening by applying multiple drugs onto cells. A process that used to take several hours can now be done in a minute. Can be used to personalise treatment and determine the susceptibility of patient cancer cells to multiple different drugs simultaneously. Â